Ad
BLUE Short Information bluebird bio Inc.
home / stock / blue / blue short
Short Information | bluebird bio Inc. (NASDAQ:BLUE)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 1,944,211 |
| Total Actual Volume | 8,398,686 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 97,211 |
| Average Short Percentage | 21.50% |
Is there a BLUE Short Squeeze or Breakout about to happen?
See the BLUE Short Analysis for free Sign up or Login
Powered by Squeeze Report
BLUE Twenty Trading Day's Volume to Short Volume Chart
BLUE Twenty Trading Day Price Chart
BLUE Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-15-2025 | $8.21 | $8.29 | $8.405 | $8 | 98,306 | 23,184 | 23.58% |
| 01-14-2025 | $8.49 | $8.01 | $8.75 | $7.96 | 196,974 | 58,540 | 29.72% |
| 01-13-2025 | $8.25 | $8.49 | $8.705 | $8.09 | 121,818 | 24,081 | 19.77% |
| 01-10-2025 | $8.42 | $8.46 | $8.79 | $8.03 | 166,368 | 25,954 | 15.6% |
| 01-08-2025 | $9 | $8.46 | $9.1682 | $8.45 | 175,693 | 28,293 | 16.1% |
| 01-07-2025 | $9.72 | $9.02 | $9.79 | $8.89 | 320,811 | 45,495 | 14.18% |
| 01-06-2025 | $9.24 | $9.92 | $10.2767 | $9.1994 | 418,233 | 66,046 | 15.79% |
| 01-03-2025 | $8.94 | $9.18 | $9.22 | $8.3 | 301,483 | 47,913 | 15.89% |
| 01-02-2025 | $8.51 | $8.69 | $9.0381 | $8.42 | 175,813 | 43,895 | 24.97% |
| 12-31-2024 | $8.12 | $8.34 | $8.5 | $7.83 | 407,759 | 87,526 | 21.47% |
| 12-30-2024 | $8.59 | $7.86 | $8.59 | $7.75 | 348,764 | 48,246 | 13.83% |
| 12-27-2024 | $8.67 | $8.78 | $9.14 | $8.55 | 251,274 | 35,054 | 13.95% |
| 12-26-2024 | $7.77 | $8.78 | $8.88 | $7.65 | 355,474 | 87,076 | 24.5% |
| 12-24-2024 | $7.63 | $7.79 | $8.24 | $7.5704 | 260,855 | 49,621 | 19.02% |
| 12-23-2024 | $8.43 | $7.66 | $8.45 | $7.605 | 426,888 | 142,667 | 33.42% |
| 12-20-2024 | $9.2 | $8.5 | $9.8 | $7.9401 | 900,856 | 155,768 | 17.29% |
| 12-19-2024 | $8.5 | $9.23 | $9.6 | $8.04 | 630,790 | 168,048 | 26.64% |
| 12-18-2024 | $9.17 | $8.41 | $9.75 | $8.02 | 780,170 | 187,686 | 24.06% |
| 12-17-2024 | $7.77 | $8.97 | $9.55 | $7.3449 | 1,107,222 | 326,732 | 29.51% |
| 12-16-2024 | $6.26 | $7.81 | $7.94 | $5.97 | 953,135 | 292,386 | 30.68% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-12-12 08:01:24 ET Bluebird bio Inc (BLUE) announced stock split at a ratio of 1-for-20 on 2024-12-13 ... Full story available on KlickAnalytics.com
-
Stable production of anti-sickling adult hemoglobin (HBA T87Q ) and elimination or significant reduction of vaso-occlusive events sustained through last follow-up for all evaluable patients (n=38), underscoring potentially transformative and durable clinical impact Results from first ...
-
Treatment effects sustained through long-term follow-up of beyond 10 years in the earliest treated patients (n=2); 81% of participants have >5 years of follow-up bluebird bio, Inc. (Nasdaq: BLUE) today announced updated data from patients with beta-thalassemia who require regular blo...